Bio-Techne TECH Cash Flow Statement (2009-2026)

NASDAQ TECH
$72.38 0.00 (-0.01%)
As of: Sep 30, 2026 · 10:05 AM EDT
Reported Financials

Bio-Techne Quarterly Cash Flow Statement

Periods 68 quarters
Latest Jun 2026

Bio-Techne reported cash from operations of $95.42M and free cash flow of $86.94M for the quarter ended Jun 2026, down 2.8% year over year. This cash flow statement covers 68 quarters of results from Sep 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
68.98M72.06M60.14M61.91M89.73M50.01M70.22M75.48M50.99M27.46M49.06M40.59M33.60M34.89M22.59M-17.68M38.19M38.01M51.05M54.62M
Share-based CompensationStock Comp.
11.74M13.97M8.07M8.41M14.46M16.74M10.11M-2.08M10.09M12.75M8.13M7.06M10.18M14.71M11.39M4.55M11.68M13.96M10.49M5.23M
Deferred Taxes
5.41M1.83M0.66M-1.07M-4.77M-1.60M-16.29M-6.92M-11.59M-10.72M-7.58M-9.55M-5.34M-8.08M-5.41M-32.28M5.28M-0.07M2.84M5.15M
Gains from Investment SecuritiesGains Investment
-5.28M-28.39M18.10M0.57M-0.91M0.07M-0.31M0.68M-0.28M
Asset Writedowns and ImpairmentWritedown
0.55M18.71M15.93M-3.65M84.16M
Cash from OperationsCash from Ops.
48.43M100.99M73.13M102.72M56.08M64.38M50.53M83.39M59.38M83.12M80.99M75.50M63.89M84.35M41.12M98.20M27.59M82.41M86.66M95.42M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
24.73M25.10M25.37M25.87M26.64M26.70M26.97M26.92M28.54M27.80M27.31M28.06M28.14M27.08M27.57M27.11M24.34M24.71M24.17M24.14M
Change in Working Capital
Change in ReceivablesChange Receivables
3.64M5.71M51.58M-3.33M-17.34M5.91M32.20M0.09M-15.60M-4.73M22.94M17.92M-21.56M0.62M15.67M-28.86M-22.39M-0.94M31.26M2.87M
Change in InventoryChange Inventory
2.98M5.72M7.33M15.97M10.69M7.68M10.45M1.35M5.22M4.36M0.02M4.62M2.81M8.91M-0.17M6.60M14.00M1.94M-3.43M-4.28M
Change in Accured ExpensesChange Accured Exp.
-18.93M8.53M21.64M1.51M-28.36M-4.91M10.51M-1.80M-2.69M8.08M1.78M18.61M-10.91M14.79M8.12M3.40M-22.10M1.39M9.51M3.53M
Change in TaxesChange Taxes
-19.82M13.72M-3.11M11.88M2.94M10.50M-9.59M-6.34M-22.94M13.05M9.88M-10.60M-6.18M-4.04M2.31M16.38M-27.40M4.58M9.79M-10.01M
Other Working Capital ChangesOther WC Changes
5.85M1.17M-3.45M-0.49M2.76M-0.76M3.55M-0.97M2.57M0.58M-1.17M1.16M3.16M-2.75M6.81M7.16M1.00M-4.26M0.75M-2.76M
Investing Activities
Capital ExpendituresCapex
6.07M10.17M15.10M13.57M9.56M6.11M11.75M10.83M13.59M14.86M16.44M17.98M9.17M6.82M10.12M4.89M5.36M5.92M9.09M8.48M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.66M4.62M
Acquisitions
101.18M166.43M3.28M
Divestments
17.82M2.15M4.85M1.40M1.25M4.64M1.35M3.27M1.42M
Cash from Investing ActivitiesCash from Investing
-7.12M-35.17M-35.99M-18.57M-19.69M-0.11M-241.10M-4.76M-154.11M-23.67M-16.44M-8.81M-21.68M-5.03M-8.87M0.41M0.60M-5.92M-5.82M-7.06M
Financing Activities
Other financing activitiesOther financing
23.25M0.00M0.16M0.09M17.85M11.00M0.05M20.23M1.07M0.17M0.43M4.98M1.01M0.29M0.23M9.23M1.25M0.16M1.50M
Cash from Financing ActivitiesCash from Financing
-39.68M-53.38M-84.06M-65.73M-31.81M-72.19M150.84M-24.22M71.51M-81.40M-52.42M-60.09M-11.57M-83.84M-68.05M-90.45M-44.20M-48.99M-42.72M-33.21M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
37.88M18.62M11.85M8.81M11.95M5.03M4.42M8.41M14.39M5.28M18.33M22.93M25.10M5.54M14.87M6.23M23.50M4.74M29.96M22.43M
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
12.49M12.58M12.58M12.54M12.54M12.56M12.58M12.60M12.65M12.56M12.58M12.63M12.69M12.74M12.58M12.39M12.44M12.47M12.52M12.48M
Dividends Paid - Common and PrefferdDiv Paid (Total)
12.49M12.58M12.58M12.54M12.54M12.56M12.58M12.60M12.65M12.56M12.58M12.63M12.69M12.74M12.58M12.39M12.44M12.47M12.52M12.48M
Additional items
Exchange Rate EffectFX Effect
-4.40M3.08M-4.09M-6.67M-11.90M7.34M2.32M-1.13M-8.69M3.42M-2.35M5.28M5.12M-5.47M-1.08M13.36M-1.21M0.41M-1.19M-0.26M
Change in Cash
-2.77M15.52M-51.02M11.75M-7.31M-0.57M-37.40M53.29M-31.91M-18.53M9.78M11.88M35.75M-9.99M-36.88M21.52M-17.22M27.92M36.94M54.89M
Free Cash FlowFCF
42.36M90.83M58.03M89.15M46.52M58.27M38.79M72.56M45.79M68.25M64.55M57.52M54.72M77.53M31.00M93.31M22.22M76.49M77.58M86.94M
Net Cash FlowNCF
1.63M12.45M-46.93M18.42M4.59M-7.92M-39.72M54.41M-23.21M-21.95M12.13M6.59M30.63M-4.52M-35.80M8.15M-16.01M27.50M38.13M55.15M

Bio-Techne Cash Flow Statement API

Pull Bio-Techne's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TECH&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY